MENU
AVIR
AS OF
Nov 13 closing price
Price
$3.06
Change
-$0.44 (-12.57%)
Capitalization
239.07M
109 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AVIR is expected to report earnings to fall 16.98% to -43 cents per share on March 03

Atea Pharmaceuticals AVIR Stock Earnings Reports
Q4'25
Est.
$-0.44
Q3'25
Missed
by $0.11
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
The last earnings report on November 12 showed earnings per share of -52 cents, missing the estimate of -41 cents. With 916.06K shares outstanding, the current market capitalization sits at 239.07M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AVIR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AVIR showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AVIR
A.I. Advisor
published General Information

General Information

a developer of vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com